Valuation: Medios AG

Market Cap 254M 286M 236M 215M 405M 27.16B 411M 2.83B 1.11B 14.17B 1.07B 1.05B 45.18B P/E 2026 *
12.2x
P/E 2027 * 8.65x
Enterprise Value 350M 394M 325M 295M 557M 37.39B 566M 3.9B 1.53B 19.51B 1.48B 1.45B 62.2B EV / Sales 2026 *
0.16x
EV / Sales 2027 * 0.14x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day+1.96%
1 week+0.58%
Current month-6.99%
1 month+2.98%
3 months-17.49%
6 months-20.15%
Current year-28.31%
1 week 10.1
Extreme 10.1
10.58
1 month 9.98
Extreme 9.98
11.52
Current year 9.98
Extreme 9.98
17.44
1 year 9.98
Extreme 9.98
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
12/8/26 Buy

Chief Financial Officer

3,500 0.0137%
4/2/26 Sell

Chief Executive Officer

13,638 0.0535%
22/1/26 Buy

Executive/Senior Manager

4,000 0.0157%
Change 5-day change 1-year change 3-year change Capi.($)
+1.96%+0.58%-22.54%-25.32% 286M
+0.43%+6.59%+53.41%+103.85% 1,120B
+0.90%-2.25%+33.02%+62.23% 616B
+0.71%+3.24%+25.81%+93.86% 504B
-0.13%+5.98%+32.91%+50.39% 367B
+0.52%+0.24%+73.92%+40.15% 360B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 258B
-0.35%+4.25%+46.21%+50.76% 234B
-0.75%+3.32%+32.53%+97.21% 194B
Average +0.04%+3.31%+29.39%+52.96% 394.12B
Weighted average by Cap. +0.13%+3.83%+39.18%+71.43%

Financials

2026 *2027 *
Net sales 2.17B 2.44B 2.01B 1.83B 3.45B 231B 3.5B 24.15B 9.47B 121B 9.15B 8.96B 385B 2.25B 2.53B 2.08B 1.89B 3.58B 240B 3.63B 25.03B 9.81B 125B 9.49B 9.28B 399B
Net income 20.93M 23.54M 19.4M 17.65M 33.3M 2.23B 33.84M 233M 91.41M 1.17B 88.36M 86.47M 3.72B 29.51M 33.19M 27.35M 24.88M 46.95M 3.15B 47.71M 329M 129M 1.64B 125M 122M 5.24B
Net Debt 95.84M 108M 88.83M 80.82M 153M 10.23B 155M 1.07B 419M 5.34B 405M 396M 17.02B 56.45M 63.51M 52.33M 47.61M 89.84M 6.03B 91.28M 629M 247M 3.15B 238M 233M 10.03B
Projected Income Statement - Annual - Medios AG
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
989
Date Price Change Volume
16/10/26 EUR 10.38 +1.96% 28,328
15/10/26 EUR 10.18 -0.78% 8,405
14/10/26 EUR 10.26 -0.58% 13,331
13/10/26 EUR 10.32 0.00% 51,142
12/10/26 EUR 10.32 0.00% 31,101
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Medios AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.38EUR
Average target price
20.25EUR
Spread / Average Target
+95.09%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Medios AG
  1. Stock Market
  2. Stocks
  3. ILM1 Stock